Substituted benzylthiazolidine-2, 4-dione derivatives
AssigneeKyorin Pharmaceutical Co., Ltd.
InventorsHiroyuki Miyachi, Masahiro Nomura, Takahiro Tanase, Koji Murakami, Masaki Tsunoda
Life of this patent
Estimating the term…
Loading patent…
AssigneeKyorin Pharmaceutical Co., Ltd.
InventorsHiroyuki Miyachi, Masahiro Nomura, Takahiro Tanase, Koji Murakami, Masaki Tsunoda
Estimating the term…
The invention provides novel substituted benzylthiazolidine-2,4-dione derivatives that bind to receptor to activate as ligands of human peroxisome proliferator-activated receptor (PPAR) and exhibit blood glucose-decreasing action and lipid-decreasing action, and processes for preparing them. It relates to substituted benzylthiazolidine-2,4-dione derivatives represented by the general formula (1) [wherein the bond mode of A denotes —CH2CONH—, —NHCONH—, —CH2CH2CO— or —NHCOCH2—, and B denotes a lower alkyl group with carbon atoms of 1 to 4, lower alkoxy group with carbon atoms of 1 to 3, halogen atom, trifluoromethyl group, trifluoromethoxy group, phenyl group which is unsubstituted or may have substituents, phenoxy group which is unsubstituted or may have substituents or benzyloxy group which is unsubstituted or may have substituents], their medicinally acceptable salts, their hydrates and processes for preparing them.
A substituted benzylthiazolidine-2,4-dione derivative represented by a general formula (1)
Dependencies are inferred from the claim text.